Enzo Biochem, Inc. (NYSE:ENZ) to Issue Quarterly Dividend of $0.10

Enzo Biochem, Inc. (NYSE:ENZ) declared a quarterly dividend on Tuesday, October 29th,NASDAQ Dividends reports. Stockholders of record on Friday, November 15th will be paid a dividend of 0.10 per share by the medical research company on Monday, December 2nd. This represents a $0.40 dividend on an annualized basis and a dividend yield of 34.93%. The ex-dividend date is Friday, November 15th.

Enzo Biochem Stock Performance

Shares of NYSE ENZ opened at $1.15 on Thursday. The business has a 50 day moving average price of $1.13 and a two-hundred day moving average price of $1.12. Enzo Biochem has a fifty-two week low of $0.99 and a fifty-two week high of $1.50.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Enzo Biochem in a report on Thursday, November 7th. They set a “hold” rating for the company.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.